Clinical Trial Update: Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing Norditropin and Nutropin AQ in healthy adult volunteers was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Norditropin (somatropin)
• Nutropin AQ (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Disorder, Healthy | Phase 1 | Status: WITHDRAWN